Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
AstraZeneca
Express Scripts
Medtronic
Merck

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Butalbital, Acetaminophen And Caffeine, and what generic alternatives are available?

Butalbital, Acetaminophen And Caffeine is a drug marketed by Aurolife Pharma Llc, Gilbert Labs, Graham Dm, Hikma Pharms, Mallinckrodt, Mayne Pharma Inc, Nexgen Pharma, Nuvo Pharms Inc, Wraser Pharms Llc, Mikart, Abhai Llc, Able, Actavis Labs Ut Inc, Cnty Line Pharms, Lannett Co Inc, Mirror Pharms Llc, Nexgen Pharma Inc, Novast Labs, Specgx Llc, Sun Pharm Industries, Vintage Pharms, and Watson Labs. and is included in thirty-two NDAs.

The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.

Summary for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Drug patent expirations by year for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Recent Clinical Trials for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 3

See all BUTALBITAL, ACETAMINOPHEN AND CAFFEINE clinical trials

Pharmacology for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Synonyms for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
122018-95-5
AC1MIWIF
Acetamide, N-(4-hydroxyphenyl)-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-(2-methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
Acetaminophen mixture with butalbital and caffeine
Acetaminophen mixture with caffeine and butalbital
ACETAMINOPHEN, BUTALBITAL AND CAFFEINE
ACETAMINOPHEN, BUTALBITAL, AND CAFFEINE
Alagesic
Amaphen
Americet
Anolor
Arcet
Butace
BUTALBITAL, APAP, AND CAFFEINE
Capacet
DTXSID50153479
Endolor
Esgic Plus
Ezol
LS-187804
Medigesic
N-(4-hydroxyphenyl)acetamide; 5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione; 1,3,7-trimethylpurine-2,6-dione
Orbivan
Pacaps
Repan
SCHEMBL2523453
Tencet
Zebutal

US Patents and Regulatory Information for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040267-001 Jul 30, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040601-001 Jul 29, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040511-001 Aug 27, 2003 AA RX No Yes   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 204733-001 Sep 26, 2018 AA RX No No   Start Trial   Start Trial   Start Trial
Gilbert Labs BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 087629-001 Nov 13, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Mirror Pharms Llc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040883-001 Dec 23, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Mallinckrodt BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 088758-001 Mar 27, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Medtronic
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.